FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Parenteral Drugs (India) LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524689 NSE Symbol: PDPL P/E (TTM) :0
ISIN Demat:INE904D01019 Div & Yield %:0 EPS (TTM) :0
Book Value (RS) :-300.6045095 Market Cap (Rs Cr.):10.11 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Mar 2022)		 Quarter Ended
(Mar 2021)		 Quarter Ended
(% Var)
Sales 1.77 2.57 -31.13
Other Income 52.21 0.00 0.00
PBIDT 46.37 3.42 1,255.85
Interest 0.00 32.46 -100.00
PBDT 46.36 -29.04 0.00
Depreciation 27.15 4.32 528.47
PBT 19.21 -33.36 0.00
Tax 0.00 0.00 0.00
Deferred Tax -4.60 -8.51 0.00
PAT 23.81 -24.84 0.00

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)